Finding tomorrow's winners by spotting today's trends.
Igor Tsukerman
Eureka Wealth Solutions
Years of Experience
29
Off-Platform Performance
PLACE HOLDER
Off-Platform Managed Assets
$23M+
Igor Tsukerman is a cofounder, CEO, and Chief Investment Officer of Eureka Wealth Solutions. Founded in 2014 and based in New York, Eureka offers a broad spectrum of traditional wealth management services and specialize in thematic investing. Identifying a trend early - due to innovation, social, demographic, economic, geopolitical, regulatory, or other reason - and investing in a portfolio of its biggest beneficiaries often leads to market outperformance. With nearly 30 years of investing experience and career spanning 15 years in biggest Wall Street companies, tech startups, running a hedge fund, and now leading a wealth management company, Igor is well-positioned and has a track record in thematic investing space.
Creator Inception Date:
January 24, 2026
Portfolios
Inception:
12/23/2012
Portfolio focuses on eVTOL aka flying cars, the technoloy holding promise to truly revolutionize transportation.
All-Time
-123%
All-Time
+123%
Inception:
Today’s amount of data and required computation can be difficult to handle. The companies providing hardware, semiconductors, and computing services, as well as the data centers are capitalizing on that trend and accelerating. Quantum computing is also included.
x
x
x
x
Inception:
The workd of green utilities does not only include companies producing sustainable energy. Companies involved in energy solutions, efficiency and management are also included. MLPs with K-1 tax forms are excluded.
x
x
x
x
Inception:
US investors often misunderstand and even mistrust foreign companies. Add a bias towards domestic markets, and some foreign stocks may become significantly mispriced. These 25 liquid ADR picks are mostly large caps, diversified by sectors and geography.
x
x
x
x
Inception:
Technology and especially AI allow for asvanced simulations to significantly speed up the traditional lab-based process of drug discovery. These companies lead the next wave of biotech.
x
x
x
x
